Search
We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Arcera and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
Latest News
Stay up-to-date with Arcera’s most recent updates.
Arcera Life Sciences reports progress on sustainability and responsible growth in 2025
Arcera Life Sciences announces the publication of its 2025 Sustainability Report, highlighting progress in embedding sustainability across its newly integrated...
Arcera Life Sciences and Daewoong Expand Strategic Partnership to Bring Enavogliflozin to...
Expansion builds on successful collaboration across Latin America and reinforces commitment to advancing innovative cardiometabolic therapies across international markets.
M42 and Arcera Partner to Advance Biopharma Localization and Next Generation Life...
Abu Dhabi, UAE – June 03, 2026: M42, a global health leader powered by technology, artificial intelligence, and genomics, and...
Emirates Drug Establishment and Arcera Sign Agreement to Advance Pharmaceutical Manufacturing in...
The partnership establishes a framework to strengthen local manufacturing, develop talent, and support long-term supply resilience. Abu Dhabi, United Arab...
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
Abu Dhabi, United Arab Emirates and Shanghai, China, April 28, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences...
Arcera Life Sciences Convenes Global Healthcare Leaders in Abu Dhabi to Accelerate...
Held during the annual “UAE Innovates” month, which aims to reinforce the UAE’s position as an international beacon of innovation,...
Arcera Life Sciences Drives Healthcare Innovation with Strategic ISPOR UAE Chapter Partnership...
Signed during the ISPOR UAE Chapter 2026 Conference in Abu Dhabi, the Memorandum of Understanding (MoU) coincides with the launch...
Ariprazol® Receives Qualification Release in the EU and Launches Sales in Latvia
Acino, part of Arcera, has obtained a qualification release for its prescription antipsychotic medicine Ariprazol® (aripiprazole) in the European Union,...
Arcera Life Sciences releases inaugural Sustainability Report
The 2024 report outlines Arcera’s current ESG initiatives and long-term ambitions, including a firm commitment to achieving full carbon neutrality...
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug...
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. («AriBio»), a South Korean biopharmaceutical company...
Media contacts
Do you need to get in touch with us?
For media enquiries, contact our Global Communications team.
